Key Takeaways
- Market snapshot: TASI at 10,946 as of March 23, 2026, down ~8% from its 2025 peak but supported by strong non-oil earnings growth.
- Access unlocked: Saudi Arabia eliminated Qualified Foreign Investor (QFI) restrictions in February 2026 — any investor can now buy TASI stocks via IBKR and other international brokers.
- Top sectors: Fintech, healthcare, and logistics are delivering the strongest revenue growth — outperforming the oil-dependent benchmark.
- Valuation gap: Leading Saudi growth stocks trade at 18–28x forward P/E versus US equivalents at 35–50x — a meaningful discount for comparable growth profiles.
- War discount: Regional conflict has created a temporary discount on TASI broadly — historically, post-conflict recoveries in Gulf markets have been sharp.
Saudi Arabia’s stock market has a perception problem in the West. Most US investors associate the Tadawul with Aramco’s IPO and little else. That is an outdated view. The TASI’s 226 non-Aramco listed companies include some of the fastest-growing financial technology, healthcare, and logistics businesses in the emerging world — and as of February 2026, the final barrier to foreign investment has been removed.
With TASI at 10,946 points in March 2026 — below its 2025 peak of approximately 12,100 — the war-related discount presents a historically unusual entry window. Here is a systematic analysis of where growth is actually occurring on the Saudi exchange.
What Changed in February 2026: The QFI Elimination
Since 2015, the Saudi Capital Market Authority required foreign institutions to register as “Qualified Foreign Investors” to buy TASI stocks directly — a process requiring minimum AUM of SAR 18.75 billion (~$5 billion), a three-year operating track record, and regulatory approval that took months. This requirement effectively excluded retail international investors and smaller institutions.
In February 2026, the CMA announced the full elimination of QFI requirements, bringing Saudi Arabia’s market access framework in line with MSCI Emerging Market standards. Any investor with a brokerage account at Interactive Brokers, Saxo Bank, or similar international brokers can now purchase TASI-listed shares directly. Settlement remains T+2, and dividend withholding tax for foreigners is 5% — among the lowest in EM.
Related: TASI’s Remarkable Disconnect from Oil Prices — 2026 Analysis.
Top Growth Sectors on TASI in 2026
Is Saudi Fintech the Biggest Opportunity?
Saudi Arabia has one of the world’s fastest-growing fintech ecosystems, driven by Vision 2030’s financial inclusion targets and a young, mobile-first population. The Saudi Central Bank (SAMA) issued 35 new fintech licenses in 2024–2025, and several licensees are now listed or preparing for IPO.
STC Pay — the payments subsidiary of Saudi Telecom, listed as a separate entity in 2024 — reported revenue growth of 41% year-over-year in its most recent earnings. Gross Transaction Volume exceeded SAR 180 billion (~$48B) in 2025, approaching the scale of mid-tier European payment processors. It trades at approximately 22x forward earnings versus Adyen at 45x and Block at 30x on comparable revenue growth trajectories.
Rasan Information Technology (listed 2023) provides digital insurance and financial services infrastructure. Revenue grew 67% in 2025 as the mandatory motor insurance market digitized and health insurance mandates expanded. Forward P/E of approximately 28x remains below comparable insurtech platforms globally.
Healthcare: A Structural Growth Story
Saudi Arabia’s healthcare sector is undergoing a structural transformation under Vision 2030. The government is privatizing public hospitals, expanding insurance mandates, and investing heavily in pharmaceutical manufacturing domestically. Healthcare spending is projected to grow from $60 billion annually (2024) to over $90 billion by 2030.
Dr. Sulaiman Al-Habib Medical Group is the flagship play. Revenue grew 22% in 2025 to SAR 7.8 billion ($2.1B), driven by hospital expansion into underserved secondary cities and the ramp-up of its IVF and oncology centers. The stock trades at approximately 24x forward earnings — a discount to comparable EM healthcare operators in India (Narayana Health, Apollo) at 35–40x.
Nahdi Medical, the largest pharmacy chain in Saudi Arabia with over 1,100 outlets, reported revenue growth of 18% in 2025. Same-store sales growth of 9% was driven by the expansion of private label products and diagnostic services. Forward P/E approximately 20x.
Logistics and E-Commerce: Riding the Non-Oil Economy
AJIL Financial Services provides fleet management and logistics financing — a direct beneficiary of the boom in last-mile delivery and Saudi e-commerce, which grew 34% in 2025 to SAR 40 billion (~$10.7B). EPS grew 55% year-over-year in the last reported quarter.
Nupco (National Unified Procurement Company for Medical Supplies) is the government’s healthcare supply chain monopoly, now listed. Revenue is contractually guaranteed and growing as the health system expands. Revenue grew 31% in 2025. Forward P/E approximately 18x with a near-monopoly moat.
Technology Infrastructure
Solutions by STC is Saudi Arabia’s largest IT services and cloud company, a subsidiary of Saudi Telecom listed separately in 2021. Revenue grew 28% in 2025 as Vision 2030 digital transformation programs accelerated and the company won large government cloud contracts. Forward P/E approximately 26x — versus Indian IT peers Infosys and TCS at 22–24x on slower growth.
Elm Company provides digital government services and identity verification — a near-monopoly on Saudi government digitization. Revenue grew 19% in 2025. The business has very high operating leverage; EPS grew 27% on 19% revenue growth. Forward P/E approximately 24x.
How Do These Compare to US Equivalents?
The valuation argument for TASI growth stocks is compelling when benchmarked against US equivalents:
- STC Pay (fintech, 41% revenue growth, 22x P/E) vs. Block/Square (28% growth, 30x P/E): Saudi fintech is cheaper on a growth-adjusted basis.
- Dr. Sulaiman Al-Habib (22% growth, 24x P/E) vs. HCA Healthcare (8% growth, 18x P/E): Saudi healthcare has a higher growth rate with only a modest valuation premium.
- Solutions by STC (28% growth, 26x P/E) vs. Cognizant (5% growth, 17x P/E): Substantially faster growth at a modest premium.
The discount reflects political risk, currency risk (SAR is pegged to USD at 3.75 — no currency risk for dollar investors), and the regional war overhang. If the war resolves, that discount compresses. For analysis of the Saudi economy’s broader trajectory, see: Saudi Arabia’s Economy and TASI Recovery Analysis.
What This Means for US Investors
US investors can now access TASI stocks directly via Interactive Brokers (ticker format: stock.SAU on IBKR). The SAR/USD peg at 3.75 eliminates currency risk — you are buying effectively in dollars. Dividend withholding tax is 5%, comparable to many EU markets. The risk-reward on leading TASI growth stocks looks asymmetric: you get India/Southeast Asia-level growth rates at 20–28x P/E rather than 30–50x, with the war discount providing an additional margin of safety. The primary risk is geopolitical escalation — specifically any scenario where Saudi territory becomes directly involved in the Iran conflict, which remains a tail risk rather than a base case. Tax treatment for US investors: gains on foreign stocks are taxed as standard capital gains; the 5% Saudi withholding on dividends can be claimed as a foreign tax credit on Form 1116.
What Are the Risks on TASI Right Now?
The most immediate risk is the regional conflict. If Iran were to target Saudi oil infrastructure — as it did in 2019 with the Abqaiq drone attack — TASI would drop sharply regardless of individual company fundamentals. The Saudi government’s decision to maintain Vision 2030 spending despite elevated defense expenditure provides a fiscal floor, but equity risk premiums could rise materially in an escalation scenario.
A secondary risk is the QFI removal creating a liquidity overshoot. If significant foreign capital enters TASI rapidly following the February 2026 deregulation, valuations could overshoot fair value — at which point the growth premium disappears. Monitor foreign investor flows via the Saudi Exchange’s weekly disclosure.
For broader context on Middle East investment opportunities and risks, see: Best Middle East ETFs and Stocks for US Investors 2026.
Frequently Asked Questions
Can US investors buy Saudi Tadawul stocks directly in 2026?
Yes, following the elimination of Qualified Foreign Investor (QFI) requirements in February 2026. US investors can purchase TASI-listed stocks directly through international brokers including Interactive Brokers (IBKR), Saxo Bank, and others that offer Saudi market access. The SAR is pegged to the USD at 3.75, eliminating currency risk. Dividend withholding tax is 5%, claimable as a foreign tax credit on Form 1116.
What is the TASI index level and how has it performed in 2026?
TASI closed at approximately 10,946 points as of March 23, 2026, representing roughly an 8% decline from its 2025 peak of ~12,100. The pullback reflects the regional war risk premium applied to all Gulf equity markets. Non-oil sector earnings within TASI have continued growing strongly — the decline is sentiment-driven rather than fundamental, creating a potential opportunity for long-term investors.
Which sectors have the strongest growth on Tadawul in 2026?
Fintech (STC Pay: 41% revenue growth), healthcare (Dr. Sulaiman Al-Habib: 22%, Nahdi: 18%), logistics technology (AJIL: 55% EPS growth), digital government services (Elm: 19% revenue, 27% EPS), and IT services (Solutions by STC: 28%) are the leading growth sectors. All benefit from Vision 2030 structural spending and expanding private sector activity.
How do Saudi growth stocks compare to Indian and US equivalents in valuation?
Leading TASI growth stocks trade at 18–28x forward P/E versus US equivalents at 30–50x on comparable growth rates, and at modest discounts to Indian EM equivalents at 25–40x. The valuation gap reflects geopolitical risk and historical underweighting of Saudi equities in international portfolios — both of which are narrowing as QFI restrictions are eliminated and regional tensions eventually subside.
What is the main risk to Saudi stocks in the current environment?
The primary risk is escalation of the Iran conflict to directly involve Saudi territory — infrastructure attacks, as seen in 2019, would trigger sharp TASI selloffs regardless of company fundamentals. A secondary risk is that the February 2026 QFI elimination triggers a rapid foreign inflow that overshoots fair value, compressing the valuation advantage. Currency risk is negligible given the SAR/USD peg.
Data sourced from Tadawul Exchange filings, company earnings releases, Saudi Capital Market Authority announcements, and analyst consensus estimates as of March 2026. This article is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results.
